Home » Stocks » TNDM

Tandem Diabetes Care, Inc. (TNDM)

Stock Price: $85.91 USD -1.07 (-1.23%)
Updated Mar 8, 2021 4:00 PM EST - Market closed
After-hours: $86.50 +0.59 (0.69%) Mar 8, 7:01 PM
Market Cap 5.37B
Revenue (ttm) 498.83M
Net Income (ttm) -34.38M
Shares Out 60.99M
EPS (ttm) -0.56
PE Ratio n/a
Forward PE 1,111.11
Dividend n/a
Dividend Yield n/a
Trading Day March 8
Last Price $85.91
Previous Close $86.98
Change ($) -1.07
Change (%) -1.23%
Day's Open 86.65
Day's Range 83.79 - 87.73
Day's Volume 970,429
52-Week Range 43.69 - 123.74

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 1 week ago

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care today announced the appointment of Jordan Pinsker, MD, to Vice President and Medical Director, effective April 26, 2021.

Zacks Investment Research - 1 week ago

Tandem Diabetes' (TNDM) strong domestic and international pump sales and shipments boosted the Q4 top line.

Business Wire - 1 week ago

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #ControlIQ--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for...

Benzinga - 1 week ago

On Wednesday, February 24, Tandem Diabetes Care (NASDAQ:TNDM) will report its last quarter's earnings. Here is Benzinga's preview of the company's release.

Zacks Investment Research - 2 weeks ago

Tandem Diabetes Care, Inc. (TNDM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 2 weeks ago

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present ...

Business Wire - 1 month ago

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2...

The Motley Fool - 1 month ago

These two providers of diabetes-related products and services have yet to scratch the surface of their potential.

Other stocks mentioned: DXCM
The Motley Fool - 2 months ago

Up 50% in 2020 with significant upside still ahead, Tandem Diabetes Care has a long runway for growth.

Zacks Investment Research - 2 months ago

Investors continue to be optimistic about Tandem Diabetes (TNDM) on robust pump sales and shipments.

Business Wire - 2 months ago

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Rajwant (Raj) Si...

Other stocks mentioned: RMD
Zacks Investment Research - 3 months ago

Tandem Diabetes' (TNDM) t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology cleared for use in Canada post the receipt of Health Canada approval.

Business Wire - 3 months ago

SAN DIEGO--(BUSINESS WIRE)-- #ControlIQ--Tandem Diabetes Care today announced Health Canada approval of the t:slim X2™ insulin pump with Control-IQ™ technology.

Zacks Investment Research - 3 months ago

Tandem Diabetes' (TNDM) strong domestic pump sales and pump shipments boosted the top line.

Zacks Investment Research - 4 months ago

At present, the New York Times (NYT), Apple (AAPL) and Tandem Diabetes Care (TNDM) are some of the few companies boasting solid earnings acceleration.

Other stocks mentioned: AAPL, NYT
Seeking Alpha - 4 months ago

Tandem Diabetes Care, Inc. (TNDM) CEO John Sheridan on Q3 2020 Results - Earnings Call Transcript

Business Wire - 4 months ago

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #ControlIQ--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for...

Business Wire - 4 months ago

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a comp...

The Motley Fool - 4 months ago

This diabetes-focused healthcare company and financial services giant are ready to reward their shareholders.

Other stocks mentioned: SQ
Business Wire - 5 months ago

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2020 results aft...

Invezz - 5 months ago

The U.S. presidential election is less than 50 days away and the health care sector could prove to be the most impacted. On Monday, Chantico Global CEO Gina Sanchez laid out on CNBC’s “Trading...

Other stocks mentioned: STE
The Motley Fool - 6 months ago

These three stocks are among the few winners to emerge from the coronavirus stock market.

Other stocks mentioned: ABT, VRTX
Business Wire - 6 months ago

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that John Sheridan, president...

Zacks Investment Research - 6 months ago

Per the DCLP5 study, Tandem Diabetes' (TNDM) insulin pump with Control-IQ technology suitable for use in children aged six to 13 years, which has been published in the NEJM.

Business Wire - 6 months ago

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #ControlIQ--Tandem announces New England Journal of Medicine publication of pediatric study showing increased time in range with Control-IQ technology.

The Motley Fool - 6 months ago

DexCom, Tandem Diabetes, and Novo Nordisk have plenty of momentum and growth ahead, making them excellent buys this month.

Other stocks mentioned: DXCM, NVO
Seeking Alpha - 7 months ago

Tandem Diabetes Care: Gaining Share In A Growing Market

Zacks Investment Research - 7 months ago

Tandem Diabetes' (TNDM) strong domestic pump sales and pump shipments boosted the top line.

Seeking Alpha - 7 months ago

Tandem Diabetes Care's (TNDM) CEO John Sheridan on Q2 2020 Results - Earnings Call Transcript

Business Wire - 7 months ago

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #ControlIQ--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for...

Business Wire - 7 months ago

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Peyton Howell as...

24/7 Wall Street - 7 months ago

With so much focus and attention geared toward the novel coronavirus and the COVID-19 pandemic, health care has been affected in many strange ways.

Other stocks mentioned: DVA, ISRG, MDT, OMI, ONEM, WBA
Business Wire - 7 months ago

DUBLIN & SAN DIEGO--(BUSINESS WIRE)--Medtronic plc (NYSE:MDT) and Tandem Diabetes Care, Inc. (NASDAQ:TNDM) today announced that they have entered into a non-exclusive patent cross-license agre...

GuruFocus - 8 months ago

Two leaders in the diabetes market are teaming up to provide a better way to administer insulin to patients.

Other stocks mentioned: ABT
Investors Business Daily - 8 months ago

Tandem Diabetes Care sees its Relative Strength Rating reach the elite 90-plus level. The post Tandem Diabetes Care Shows Market Leadership With Jump To 94 RS Rating appeared first on Investor...

Zacks Investment Research - 8 months ago

Abbott's (ABT) FreeStyle Libre CGM technology to be integrated with Tandem Diabetes' insulin pumps to enhance diabetes care.

Other stocks mentioned: ABT
Zacks Investment Research - 8 months ago

Tandem Diabetes (TNDM) expands digital portfolio with the Sugarmate app buyout, paving the way for the company's expansion of diabetes-related products and services ecosystem.

The Motley Fool - 8 months ago

Which of these two diabetes partners is more likely to be the bigger winner over the long run?

Other stocks mentioned: DXCM
Zacks Investment Research - 8 months ago

Tandem Diabetes (TNDM) receives clearance for expanded indication for pediatric use of t:slim X2 insulin pump with Control-IQ, paving the way for simpler diabetes management in younger patient...

Zacks Investment Research - 8 months ago

Tandem Diabetes (TNDM) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Zacks Investment Research - 8 months ago

Amid the widespread pandemic crisis, the diabetes management sector continues to thrive on account of multiple positive developments

Other stocks mentioned: ABT, DXCM
Zacks Investment Research - 9 months ago

Strong domestic pump sales and international expansion boosts sales of Tandem Diabetes (TNDM).

Zacks Investment Research - 9 months ago

Investors continue to be optimistic about Tandem Diabetes (TNDM) on robust pump sales and international growth.

Investors Business Daily - 9 months ago

Several top health care stocks are in buy zones or setting up, including Teladoc and Neurocrine Biosciences. They are all worth adding to your watchlist.

Other stocks mentioned: BMY, NBIX, QDEL, TDOC
The Motley Fool - 9 months ago

These two diabetes companies have been beating the market all year long, but that’s not the only reason you should consider investing in them.

Other stocks mentioned: LLY
Zacks Investment Research - 10 months ago

Tandem Diabetes' (TNDM) strong domestic pump sales and the company's expansion in international markets boost the top line.

Seeking Alpha - 10 months ago

Tandem Diabetes Care, Inc. (TNDM) CEO John Sheridan on Q1 2020 Results - Earnings Call Transcript

The Motley Fool - 10 months ago

Investors might consider the company's products to be essential, but the business could face temporary problems getting products into the hands of new customers.

Zacks Investment Research - 10 months ago

Investors continue to be optimistic about Tandem Diabetes (TNDM) on its strength in the diabetes business and receipt of regulatory approvals.

Seeking Alpha - 10 months ago

Tandem Diabetes Care: This Is A Coronavirus-Resilient Pick For April 2020

About TNDM

Tandem Diabetes Care, a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In add... [Read more...]

Industry
Medical Devices
IPO Date
Nov 14, 2013
CEO
John Sheridan
Employees
1,500
Stock Exchange
NASDAQ
Ticker Symbol
TNDM
Full Company Profile

Financial Performance

In 2020, TNDM's revenue was $498.83 million, an increase of 37.68% compared to the previous year's $362.31 million. Losses were -$34.38 million, 38.9% more than in 2019.

Financial Statements

Analyst Forecasts

According to 15 analysts, the average rating for TNDM stock is "Buy." The 12-month stock price forecast is 127.67, which is an increase of 48.61% from the latest price.

Price Target
$127.67
(48.61% upside)
Analyst Consensus: Buy